PUBLISHER: Grand View Research | PRODUCT CODE: 1587582
PUBLISHER: Grand View Research | PRODUCT CODE: 1587582
The global automated visual field analyzer market size is expected to reach USD 300.0 million by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% from 2025 to 2030. The market is expected to witness lucrative growth during the forecast period owing to factors such as an increase in the prevalence of ocular disorders, such as glaucoma, cataract, and diabetes retinopathy, a growing geriatric population, and the introduction of a technologically advanced automated visual field analyzer for the diagnosis. Additionally, the growing frequency of new product launches and the rise in the incidence of ocular diseases such as glaucoma and cataract are key drivers of the market.
The number of people with visual impairment and blindness is anticipated to rise significantly as a result of COVID-19's global effects on eye health, population aging, environmental changes, and lifestyle shifts. Globally, there are at least 2.2 billion people who struggle with near or far vision. However, Covid-19 has had a negative effect on the market for automated visual field analyzers due to factors such as the postponement of elective hospital treatments, including eye exams, and the risk of infection, which has caused a decrease in the number of people visiting eye clinics. The market is also being constrained by factors like a lack of ophthalmologists, price pressure, rising competition, and excessive costs.
Many public and private organizations are taking steps to raise awareness regarding eye health and vision care among the general public, optometrists, and ophthalmologists for the diagnosis and treatment of ophthalmic diseases, such as conducting awareness and advertising campaigns and workshops. Additionally, several suppliers provide ophthalmologists and technician's hands-on training in visual field analyzers through courses, tutorials, and workshops. Such activities assist to raise knowledge about ocular illnesses and accessible diagnostic equipment, such as ophthalmic perimeters, which will drive the market.